CATO SMS is a full-service clinical and regulatory contract research organization (CRO), specializing in complex areas such as (immuno-) oncology, advanced therapeutics and orphan diseases. We offer regulatory consulting and drug development affairs in addition to clinical trial management services, leveraging the experience and expertise in all disciplines to the full benefit of your company. We are committed to supporting small and mid-sized biotech, top-tier pharmaceutical companies and investigator groups from strategy to approval, from phase I to IV. CATO SMS employs over 320 dedicated professionals with offices and operations in over 25 countries around the globe including the United States (US), Canada, Europe, Israel and South Africa. Offices are strategically located close to the European Medicines Agency (EMA) in Amsterdam, the Netherlands, and the Food and Drug Administration (FDA) in Washington, US.